OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value
$7.34−1.53 (-17.25%)
Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –
OptimizeRx ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
OptimizeRx's ebitda for the twelve months ending Sep 30, 2026 was $15.77M, up 41.4% year over year. For fiscal 2025 it was $16.02M. The highest annual figure on record is $16.02M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.02M | – |
| FY2024 | Dec 31, 2024 | -$9.38M | – |
| FY2023 | Dec 31, 2023 | -$24.00M | – |
| FY2022 | Dec 31, 2022 | -$10.27M | -541.4% |
| FY2021 | Dec 31, 2021 | $2.33M | – |
| FY2020 | Dec 31, 2020 | -$59.43K | – |
| FY2019 | Dec 31, 2019 | -$2.41M | -585.4% |
| FY2018 | Dec 31, 2018 | $496.63K | – |
| FY2017 | Dec 31, 2017 | -$1.81M | – |
| FY2016 | Dec 31, 2016 | -$1.35M | – |
| FY2015 | Dec 31, 2015 | -$263.46K | – |
| FY2014 | Dec 31, 2014 | -$761.99K | – |
| FY2013 | Dec 31, 2013 | -$73.75K | – |
| FY2012 | Dec 31, 2012 | -$267.82K | – |
| FY2011 | Dec 31, 2011 | -$1.31M | – |
| FY2010 | Dec 31, 2010 | -$1.79M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.73M | +18.5% |
| Q2 FY2026 | Jun 30, 2026 | $976.00K | -77.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.46M | – |
| Q4 FY2025 | Dec 31, 2025 | $9.60M | +103.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.15M | – |
| Q2 FY2025 | Jun 30, 2025 | $4.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.01M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.47M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.96M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.38M | -535.7% |
| Q1 FY2023 | Mar 31, 2023 | -$6.60M | -1269.6% |
| Q4 FY2022 | Dec 31, 2022 | -$407.80K | -121.8% |
| Q1 FY2022 | Mar 31, 2022 | -$3.29M | -1048.8% |
| Q4 FY2021 | Dec 31, 2021 | $1.01M | – |
| Q3 FY2021 | Sep 30, 2021 | $564.23K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.87M | +161.1% |
| Q3 FY2020 | Sep 30, 2020 | $346.70K | +7.5% |
| Q2 FY2020 | Jun 30, 2020 | -$535.02K | -2035.9% |
| Q1 FY2020 | Mar 31, 2020 | -$1.74M | -726.5% |
| Q2 FY2019 | Jun 30, 2019 | $715.62K | +118.1% |
| Q1 FY2019 | Mar 31, 2019 | $322.47K | – |
| Q4 FY2018 | Dec 31, 2018 | $27.64K | – |
| Q3 FY2018 | Sep 30, 2018 | $277.65K | – |
| Q2 FY2018 | Jun 30, 2018 | $328.07K | – |
| Q1 FY2018 | Mar 31, 2018 | -$136.72K | – |
| Q4 FY2017 | Dec 31, 2017 | -$127.67K | – |
| Q3 FY2017 | Sep 30, 2017 | -$558.69K | – |
| Q2 FY2017 | Jun 30, 2017 | -$299.59K | – |
| Q1 FY2017 | Mar 31, 2017 | -$819.47K | – |
| Q4 FY2016 | Dec 31, 2016 | -$286.61K | – |
| Q3 FY2016 | Sep 30, 2016 | -$196.58K | – |
| Q2 FY2016 | Jun 30, 2016 | -$551.46K | – |
See a number that looks wrong?